THERAPEUTIC SEGMENT:
Antihypertensive

INDICATIONS:
Co-Valid is indicated for the treatment of hypertension, to lower blood pressure:
In patients not adequately controlled with monotherapy.
As initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.

BRIEF DESCRIPTION:
Co-Valid is the combination tablet of valsartan, an angiotensin II receptor blocker (ARB) and hydrochlorothiazide (HCTZ), a diuretic.

DOSAGE FORM:

Tablets
80/12.5
160/12.5
160/25